DỮ LIỆU BÁO CÁO THƯỜNG NIÊN
CÁC CÔNG TY NIÊM YẾT NƯỚC NGOÀI

Báo cáo thường niên năm 2021 của 4basebio PLC

4basebio PLC is developing next generation gene therapy technologies and solutions. 4basebio started with a focus on the manufacture of synthetic DNA for use in gene therapies; their synthetic DNA has clear safety, efficacy, and cost benefits over current plasmid DNA. Their near-term objective is the development of Good Manufacturing Practice (“GMP”) grade synthetic DNA as a key milestone … More in the commercialisation of this core technology.

TÊN CÔNG TY / COMPANY
4basebio PLC

SÀN CHỨNG KHOÁN / STOCK EXCHANGE
LSE (England)

MÃ CHỨNG KHOÁN / TICKER
4BB

KỲ BÁO CÁO
2021

NGÀNH / INDUSTRY
Biotechnology

LĨNH VỰC / SECTOR
Healthcare